دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke
Daniel E. Singer, MD; Paul D. Ziegler, MS; Jodi L. Koehler, MS; et al.
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes
Zachary T. Yoneda, MD, MSCI; Katherine C. Anderson, MS, CSG; Joseph A. Quintana, MD; et al.
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial
Mario Gaudino, MD, PhD; Katia Audisio, MD; Mohamed Rahouma, MD; et al.
Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular EventsThe ENGAGE Randomized Clinical Trial
Mitesh S. Patel, MD, MBA; Chethan Bachireddy, MD, MS; Dylan S. Small, PhD; et al.
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure LoweringFindings From the SPRINT Randomized Clinical Trial
Jarett D. Berry, MD; Vijay Nambi, MD, PhD; Walter T. Ambrosius, PhD; et al.
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events
Yiyi Zhang, PhD; Mark J. Pletcher, MD, MPH; Eric Vittinghoff, PhD; et al.
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US
Muthiah Vaduganathan, MD, MPH; Brian L. Claggett, PhD; Stephen J. Greene, MD; et al.
Association of Mortality With Aortic Stenosis Severity in OutpatientsResults From the VALVENOR Study
Augustin Coisne, MD, PhD; David Montaigne, MD, PhD; Samy Aghezzaf, MD; et al.
Gender Differences in Medicare Payments Among Cardiologists
Inbar Raber, MD; Mahmoud Al Rifai, MD, MPH; Cian P. McCarthy, MB, BCh, BAO; et al.
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome
Gorav Batra, MD, PhD; Tatevik Ghukasyan Lakic, MSc; Johan Lindbäck, MSc; et al.
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
Audrey Dionne, MD; Francesca Sperotto, MD; Stephanie Chamberlain; et al.
Premature Menopause and 10-Year Risk Prediction of Atherosclerotic Cardiovascular Disease
Priya M. Freaney, MD; Hongyan Ning, MD, MS; Mercedes Carnethon, PhD; et al.
The Challenge of Estimating Treatment Effects in Cardiac Surgery
Mario Gaudino, MD, PhD, MSCE; Mary Charlson, MD, MSCE; Frank Sellke, MD
An Expanded Heart Failure Indication for Sacubitril/ValsartanEvolving the Evidence Bar
Clyde W. Yancy, MD, MSc
Early-Onset Atrial Fibrillation and Heritable Heart Disease—To Test or Not to Test?
Gordon F. Tomaselli, MD; Megan J. Roy-Puckelwartz, PhD
Coronary Artery Bypass Grafting With the Internal Thoracic ArteryA Great Operation With Some Unanswered Questions
Frank W. Sellke, MD
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus ThrombosisA Review
John G. Rizk, RPh, MSc; Aashish Gupta, MD; Partha Sardar, MD; et al.
Multiple Systemic Lesions in a Middle-aged Woman With a History of Lymphoma
Deacon Z. J. Lee, MBChB, CCDS; Elsie T. Nguyen, MD; Harry Rakowski, MD
Recurrent Paravalvular Leak Following Mitral Valve Replacement
Badar Patel, MD; Musa A. Sharkawi, MBBCh; Pinak B. Shah, MD
Assessing Performance of Machine Learning
Konrad Pieszko, MD, PhD; Piotr J. Slomka, PhD
Assessing Performance of Machine Learning—Reply
Rohan Khera, MD, MS; Bobak J. Mortazavi, PhD; Harlan M. Krumholz, MD, SM
Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk
Gloria Aguilo, MD; Isabel Vinuela, MD; Sergio Verd, MD
Early-Life Initiation of Primary Prevention Strategies to Reduce Atherosclerosis Risk—Reply
Matthew K. Armstrong, PhD; Brooklyn J. Fraser, PhD; Costan G. Magnussen, PhD
Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate
Yonathan Freund, MD, PhD; Mélanie Roussel, MD; Wilhelm Behringer, MD, MBA, MSC
Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate—Reply
Pierre-Marie Roy, MD, PhD; Thomas Moumneh, MD; Andrea Penaloza, MD, PhD
It’s Time to Rethink (and Retrial) Our Framework for Stroke Prevention in Atrial Fibrillation
Mintu P. Turakhia, MD, MAS
Transforming the Paradigm for Lipid Lowering
Ann Marie Navar, MD, PhD; Gregg C. Fonarow, MD
